N
BHVN

Nuveen’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Nuveen’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-213,362
Closed -$17.7M – 3329
2022
Q3 		$17.7M Sell
213,362
-7,333
-3% -$1.09M 0.01% 1100
2022
Q2 		$18.3M Buy
220,695
+24,177
+12% +$3.09M 0.01% 1096
2022
Q1 		$23M Sell
196,518
-2,941
-1% -$367K 0.01% 1105
2021
Q4 		$21M Sell
199,459
-21,597
-10% -$2.75M 0.01% 1206
2021
Q3 		$29.8M Sell
221,056
-8,460
-4% -$1.06M 0.01% 997
2021
Q2 		$22.3M Buy
229,516
+5,407
+2% +$439K 0.01% 1277
2021
Q1 		$15.3M Sell
224,109
-147,324
-40% -$11.9M ﹤0.01% 1517
2020
Q4 		$31.8M Buy
371,433
+95,799
+35% +$8.12M 0.01% 948
2020
Q3 		$17.9M Sell
275,634
-25,496
-8% -$1.67M 0.01% 1121
2020
Q2 		$22M Buy
301,130
+116,876
+63% +$6.22M 0.01% 983
2020
Q1 		$6.27M Sell
184,254
-280,553
-60% -$12.8M ﹤0.01% 1578
2019
Q4 		$25.3M Sell
464,807
-402,265
-46% -$19.9M 0.01% 1038
2019
Q3 		$36.2M Sell
867,072
-18,953
-2% -$801K 0.01% 824
2019
Q2 		$38.8M Buy
+886,025
New +$49.9M 0.02% 814

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Nuveen's BHVN Position: Q4 2022 in Review

Nuveen sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 213,362 shares — an estimated $17.7M sold.

Nuveen first reported a position in BHVN in Q2 2019 and held it in 14 quarters. The position peaked at $38.8M in Q2 2019. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Nuveen reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 213,362 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $17.7M.
  • Nuveen first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 14 quarters.
  • Nuveen's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $38.8M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.